Primus In News
Precision oncology gains ground as India clears targeted cancer therapies
25-12-2025
Nilaya Varma, Group CEO and Co-Founder,Primus Partners, highlights that the approvals represent a major step toward integrating outcome-based precision medicine into routine cancer care, with combination immunotherapies improving treatment outcomes for patient groups that previously had limited options.
Explore Related Insights
- A growth-oriented, digital savvy, infrastructure-focused budget
- India’s care economy poised to create 60 mn jobs and unlock $300 bn growth by 2030: Report
- Students see entrepreneurship as a core pathway to careers and growth
- Budget 2021: Healthcare likely to be top priority, says Assocham-Primus Partners’ survey
